Andropause
Andropause refers to the age-associated, gradual decline in male sex hormones — especially testosterone — over decades. Unlike menopause in women, andropause is not a sudden shutdown; hormone levels slowly decrease (often ~1% per year after age 30) and clinical symptoms may or may not appear depending on individual physiology.
Because the decline happens gradually, many clinicians prefer to call it “late-onset hypogonadism” or “age-related testosterone deficiency.”
Common symptoms
In men experiencing significant testosterone decline, possible symptoms include:
Low libido, decreased sexual desire or performance, erectile dysfunction
Decreased energy, fatigue, reduced muscle mass and strength, increased body fat, altered body composition
Mood changes: low mood, irritability, reduced motivation or vitality
Cognitive changes: memory, concentration, mental clarity (in some)
Reduced bone density and increased risk of osteoporosis or fractures (over time)
Decreased general well-being, vitality, possibly mild anemia due to decreased blood cell production
However, many men with declining testosterone never develop symptoms; the condition is variable and multifactorial (age, lifestyle, comorbidity, receptor sensitivity).
Common hormone therapy prescriptions / interventions
When clinically indicated (i.e. low testosterone confirmed + convincing symptoms), testosterone replacement therapy (TRT) may be considered. Options include:
Testosterone gels, creams, patches
Injectable testosterone formulations, with regular dosing to maintain steady levels
Therapy decisions consider age, cardiovascular health, prostate health, fertility intentions, baseline labs, and risk-benefit balance.
How hormone therapy may improve symptoms
Properly dosed and monitored TRT may provide benefits such as:
Improved libido, sexual function, and erectile quality
Increased muscle mass and strength; improved body composition (less fat, more lean mass)
Enhanced mood, energy, motivation, mental clarity in some men
Potential benefit to bone density over time, reducing fracture risk in men with significant androgen deficiency
Important caveats & monitoring
Not all men with declining testosterone will benefit — symptoms should guide decision, not just lab numbers. Many men with low levels have no symptoms.
Because TRT may have risks (cardiovascular, prostate, hematocrit increase), careful baseline evaluation and periodic monitoring is required: testosterone levels, hematocrit/Hb, prostate-specific antigen (PSA) (if indicated), lipids, and overall health.
Lifestyle modifications (weight management, exercise, sleep, stress reduction) remain foundational; hormones should not be viewed as a “magic bullet.”